Physician profile
Bradley J Reddick
NPI 1932310596
$572,520.30
in general payments reported to CMS, 2019-2025
14 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138K · 2020: $81K · 2021: $103K · 2022: $114K · 2023: $42K · 2024: $54K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $111K · Travel and Lodging: $21K · Food and Beverage: $4,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $111,362.50 |
| Travel and Lodging | $21,205.38 |
| Food and Beverage | $4,340.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $570,545.66 | 2019-2025 | Mako, Aequalis, Insignia |
| Omnilife Science, INC | $780.61 | 2019-2025 | |
| Conmed Corporation | $411.77 | 2021-2022 | |
| Nextstep Arthropedix, LLC | $119.20 | 2019-2020 | |
| Smith+Nephew, INC. | $113.82 | 2021 | |
| Davol INC. | $111.10 | 2023 | |
| Zimmer Biomet Holdings, INC. | $106.09 | 2019 | |
| Depuy Synthes Sales INC. | $103.57 | 2019-2022 | |
| Lima USA, INC. | $69.23 | 2019 | |
| Medtronic, INC. | $43.11 | 2025 | Inceptiv |
| Innovation Technologies INC | $42.36 | 2024-2025 | Irrisept |
| Ethicon US, LLC | $34.74 | 2019 | |
| Pylant Medical | $24.73 | 2021 | |
| Pacira Therapeutics, INC. | $14.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Reddick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.